Qitan Tech

Qitan Tech

Private
ChengduHealthcare & Life Scienceshttp://www.qitantech.com

Last Round

Series C

Extension

Dec 27, 2023

Total Funding Raised

$196.4M

Momentum Score

25 /100

Company Overview

Qitan Tech is a biotechnology company that develops and manufactures nanopore gene sequencers, supporting flow cells, and reagents.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

nanopore sequencinglong-read sequencingnanopore sequencersthird-generation sequencing3rd gen sequencingflow cellssingle-molecule sequencinggene sequencersnext-generation sequencingNGSreal-time sequencingsequencing reagentsportable sequencerdirect RNA sequencingpathogen identificationrazor and blades modelbioinformatics softwaremolecular diagnosticsbiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qitan Tech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Qitan Tech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionDec 27, 2023
Series CDec 23, 2022
Series BJun 8, 2021
Series AMay 13, 2020
StrategicAug 10, 2019

Qitan Tech Investors

Notable investors and investment history

InvestorRounds
BioTrack CapitalSeries B, Series C
Yinxinggu CapitalSeries A
Zhongguancun Co-Innovation FundSeries B
GL VenturesSeries B
Ginkgo Valley CapitalSeries B
Huagai CapitalSeries B, Series C
CDH VGCSeries B

Qitan Tech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qitan Tech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qitan Tech's valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Employee Range7
Year Founded2016
Last FundingDec 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.